Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Corgenix collaborates with Randox to automate AspirinWorks Test

Corgenix Medical : 07 April, 2008  (Company News)
Corgenix Medical has entered into an agreement with Randox Laboratories, a diagnostic company with headquarters in Crumlin, United Kingdom, to expand the test processing technology and distribution network of the Corgenix AspirinWorks product.
Under the terms of the agreement, the companies will collaborate in adapting the Corgenix AspirinWorks test to a format compatible with automated chemistry analysers. The AspirinWorks test will be manufactured at Randox facilities in the United Kingdom, and the two companies will share global distribution rights.

'We are very pleased about this new relationship with Randox. They are one of the world's premier diagnostic companies in automated technology, and together we expect to adapt the important AspirinWorks product into a format suitable for high volume clinical testing,' said Douglass Simpson, Corgenix president and chief executive officer. 'A key factor in the future success of the AspirinWorks product will be automation. We are confident that our collaboration with Randox will result in a successful launch of the new product format next year.'

AspirinWorks is a simple urine test that determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin's target). The higher the levels of thromboxane, the stickier the blood platelets, and the less impact the aspirin is having. This crucial information allows physicians to individualise a patient's aspirin therapy.

Unlike other platelet tests, which require freshly drawn blood that must be evaluated within at least 4 hours, the current AspirinWorks test only requires a urine sample that can be obtained in any doctor's office or patient service centre, making the test easy for both physician and patient.

'We know that not all individuals respond to aspirin the same and lack of aspirin effect should be a concern of anyone taking aspirin to prevent heart attack and stroke,' said Corgenix' clinical affairs director Gordon Ens. 'Marrying our AspirinWorks product to automated technologies by means of Randox expertise is a great opportunity for addressing the long-term needs of clinical testing laboratories.'

Simpson said the collaborative agreement with Randox is particularly important for the AspirinWorks test and for Corgenix because it lays a solid foundation for growth and signals future collaborations on a number of other products and technologies between the two companies.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo